Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Italfarmaco Sa Drug Patent Portfolio

Italfarmaco Sa owns 1 orange book drug protected by 1 US patent Given below is the list of Italfarmaco Sa's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8765150 Riluzole aqueous suspensions 12 Mar, 2029
Active


Given below is the list of recent legal activities going on the following drug patents of Italfarmaco Sa.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Year, Large Entity 03 Jan, 2022 US8765150
Payment of Maintenance Fee, 4th Year, Large Entity 02 Jan, 2018 US8765150
Patent Issue Date Used in PTA Calculation
Critical
01 Jul, 2014 US8765150
Recordation of Patent Grant Mailed
Critical
01 Jul, 2014 US8765150
Email Notification
Critical
12 Jun, 2014 US8765150
Issue Notification Mailed
Critical
11 Jun, 2014 US8765150
Dispatch to FDC 29 May, 2014 US8765150
Printer Rush- No mailing 27 May, 2014 US8765150
Mail Miscellaneous Communication to Applicant 27 May, 2014 US8765150
Email Notification
Critical
27 May, 2014 US8765150
Application Is Considered Ready for Issue
Critical
22 May, 2014 US8765150
Miscellaneous Communication to Applicant - No Action Count 20 May, 2014 US8765150
Pubs Case Remand to TC
Critical
16 May, 2014 US8765150
Issue Fee Payment Received
Critical
15 May, 2014 US8765150
Issue Fee Payment Verified
Critical
15 May, 2014 US8765150


Italfarmaco Sa's Family Patents

Italfarmaco Sa drugs have patent protection in a total of 21 countries. It's US patent count contributes only to 4.3% of its total global patent coverage. 4 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Italfarmaco Sa Drug List

Given below is the complete list of Italfarmaco Sa's drugs and the patents protecting them.


1. Tiglutik Kit

Tiglutik Kit is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8765150 Riluzole aqueous suspensions 12 Mar, 2029
(4 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tiglutik Kit's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List